Continuous Versus Intermittent Enteral Feeding in Critically Ill Patients
NCT ID: NCT02159456
Last Updated: 2021-08-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
70 participants
INTERVENTIONAL
2014-05-31
2021-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* However, in critically ill patients, the smooth progress of nutritional support is often hindered by gastrointestinal intolerance, underlying clinical condition, and temporal necessity of procedure or operation.
* Continuous feeding method, compared with intermittent feeding, is expected to reduce the risk of gastrointestinal intolerance, and improve the nutritional support, but this hypothesis is not supported by appropriate evidences.
2. We will elucidate to compare the efficacy and safety of the continuous feeding method in critically ill patients, compared with the intermittent feeding method.
* Prospective, randomized controlled study
* Primary outcome: the achievement rate of target nutritional goal within 7 days after the start of enteral nutrition
* Secondary outcome: gastrointestinal tolerance, In-ICU/hospital mortality, frequency of hospital-acquired infection, ICU/hospital length-of-stay, duration of mechanical ventilation
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A More Physiological Feeding Process in ICU:the Intermittent Infusion With Semi-solidification of Nutrients
NCT03017079
Daytime Cyclic Enteral Nutrition Versus Standard Continuous Enteral Nutrition in the Intensive Care Unit: a Pilot Randomized Controlled Trial
NCT05627167
Feasibility, Safety, and Outcomes of Intensive Enteral Nutrition in Patients With Mechanical Ventilation
NCT02897713
Comparison of Continuous Versus Intermittent Enteral Nutrition in Critically Ill Patients.
NCT03573453
The Effect of Standardized Enteral Nutrition on Critically Ill Patients
NCT02976155
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Continuous enteral feeding
Continuous enteral feeding via infusion pump is applied for at least 7 days after the start of enteral feeding
Continuous enteral feeding via infusion pump
Intermittent enteral feeding
Intermittent enteral feeding via gravity-based infusion is applied for at least 7 days after the start of enteral feeding.
Intermittent enteral feeding via gravity-based infusion
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Continuous enteral feeding via infusion pump
Intermittent enteral feeding via gravity-based infusion
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* age 20 years old or more
* The enteral nutritional support is expected to be available within 48 hours after ICU admission
Exclusion Criteria
* gastrointestinal bleeding, bowel obstruction, refractory vomiting/diarrhea
* hypersensitivity to prokinetics, history of seizure or phechromocytoma
* enteral feeding via enterostomy or gastrostomy
* difficulty to insert or maintain nasogastric tube
* need for specialized feeding (ex: hemodialysis diet, chronic renal failure diet, diabetes diet)
* pregnancy
20 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Seoul National University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jinwoo Lee
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Seoul National University Hospital
Seoul, Daehak-ro, Jongno-gu, South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
feed520
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.